Dyslipidemia in seven Latin American cities: CARMELA study

Preventive Medicine

Volumn 50, Issue 3, 2010, Pages 106-111

  Vinueza, Raul ^a   Boissonnet, Carlos Pablo ^b   Acevedo, Monica ^c   Uriza, Felipe ^d   Benitez, Francisco Jose ^e   Silva, Honorio ^a   Schargrodsky, Herman ^f   Champagne, Beatriz ^g   Wilson, Elinor ^h  

^a InterAmerican Foundation for Clinical Research   (United States)

^b CEMIC   (Argentina)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^e HOSPITAL METROPOLITANO   (Ecuador)

^f HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^g InterAmerican Heart Foundation   (United States)

^h UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cross sectional studies; Dyslipidemia; Latin America; Urban population

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARGENTINA; ARTICLE; CARDIOVASCULAR RISK; CHILE; CHOLESTEROL BLOOD LEVEL; COLOMBIA; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ECUADOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PERU; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SOUTH AND CENTRAL AMERICA; TRIACYLGLYCEROL BLOOD LEVEL; VENEZUELA;

ADULT; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED;

EID: 77149180766     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.12.011     Document Type: Article

References (36)

1. al-Nuaim A.R. Serum total and fractionated cholesterol distribution and prevalence of hypercholesterolemia in urban and rural communities in Saudi Arabia. Int. J. Cardiol. 1997, 58(2):141-149.
2. Assmann G., Cullen P., Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur. Heart J. 1998, 19(Suppl A):A2-A11.
3. Assmann G., Gotto A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 109(23 Suppl 1):III8-III14.
4. Bautista L., Oróstegui M., Vera L., Prada G., Orozco L., Herrán O. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey. European Journal of Cardiovascular Prevention & Rehabilitation 2006, 13(5).
5. Beaglehole R., Ebrahim S., Reddy S., Voute J., Leeder S. Prevention of chronic diseases: a call to action. Lancet 2007, 370(9605):2152-2157.
6. Bittner V., Hardison R., Kelsey S.F., Weiner B.H., Jacobs A.K., Sopko G. Bypass angioplasty revascularization investigation. non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002 Nov 12, 106(20):2537-2542.
7. Bonita R., de Courten M., Dwyer T., Jamrozik K., Winkelmann R. Surveillance of Risk Factors for Non Communicable Disease. The WHO Stepwise Approach 2001, WHO.
8. Campos H., Mata L., Siles X., Vives M., Ordovas A., Schaefer E.J. Prevalence of cardiovascular risk factors in rural and urban Costa Rica. Circulation 1992, 85:648-658.
9. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996, 124(Suppl):S1-S9.
10. Ciruzzi M., Schargrodsky H., Pramparo P., et al. Attributable risks for acute myocardial infarction in four countries of Latin America. Medicina (B Aires) 2003, 63(6):697-703.
11. Criqui M.H., Golomb B.A. Epidemiologic aspects of lipid abnormalities. Am. J. Med. 1998, 105(1A):48S-57S.
12. Cui Y., Blumenthal R.S., Flaws J.A., et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch. Intern. Med. 2001, 161(11):1413-1419.
13. de Souza L.J., Souto Filho J.T., de Souza T.F., et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol. 2003, 81(3):249-264.
14. Ezzati M. How can cross-country research on health risks strengthen interventions? Lessons from INTERHEART. Lancet 2004, 364(9438):912-914.
15. Ezzati M., Vander Hoorn S., Lawes C.M., et al. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005, 2(5):e133.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18(6):499-502.
17. Gaziano T.A., Galea G., Reddy K.S. Scaling up interventions for chronic disease prevention: the evidence. Lancet 2007, 370(9603):1939-1946.
18. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989, 79(1):8-15.
19. Grover S.A., Palmer C.S., Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch. Intern. Med. 1994, 154(6):679-684.
20. Grundy S.M., Cleeman J.I., Merz C.N., et al. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [published correction appears in Circulation. 2004;110(6):763]. Circulation 2004, 110(2):227-239.
21. International Money Fund. World Economic Outlook Database 2007. Available at: Accessed March 3, 2008. http://imf.org/external/pubs/ft/weo/2007/02/weodata/index.aspx.
22. Kinosian B., Glick H., Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann. Intern. Med. 1994, 121(9):641-647.
23. Lanas F., Avezum A., Bautista L.E., et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007, 115(9):1067-1074.
24. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ 1994, 308(6925):367-372.
25. Menotti A., Keys A., Kromhout D., et al. Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the seven countries study. Eur. J. Epidemiol. 1993, 9(5):527-536.
26. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
27. Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005, 112(22):3375-3383.
28. Ridker P.M., Rifai N., Cook N.R., Bradwin G., Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005, 294(3):326-333.
29. Schargrodsky H., Hernandez-Hernandez R., Champagne B., et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am. J. Med. 2008, 121(1):58-65.
30. Touboul P.J., Hernandez-Hernandez R., Kucukoglu S., et al. Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA Study. Int. J. Cardiovasc. Imaging 2006.
31. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
32. World Health Organization, (2007a) Cardiovascular disease. Strategic priorities of the WHO Cardiovascular Disease Programme. Available at: Accessed 2/9/07. http://www.who.int/cardiovascular_diseases/priorities/en/.
33. World Health Organization, (2007b) Global InfoBase Online. Available at: Accessed 2/9/07. http://www.who.int/ncd_surveillance/infobase/web/InfoBasePolicyMaker/reports/.
34. Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004, 291(21):2616-2622.
35. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952.
36. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104(22):2746-2753.